Department of Medicine, Washington University School of Medicine, St. Louis, MO.
Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.
Hepatology. 2019 Oct;70(4):1168-1184. doi: 10.1002/hep.30669. Epub 2019 May 23.
The mechanisms by which alterations in intestinal bile acid (BA) metabolism improve systemic glucose tolerance and hepatic metabolic homeostasis are incompletely understood. We examined metabolic adaptations in mice with conditional intestinal deletion of the abetalipoproteinemia (ABL) gene microsomal triglyceride transfer protein (Mttp-IKO), which blocks chylomicron assembly and impairs intestinal lipid transport. Mttp-IKO mice exhibit improved hepatic glucose metabolism and augmented insulin signaling, without weight loss. These adaptations included decreased BA excretion, increased pool size, altered BA composition, and increased fibroblast growth factor 15 production. Mttp-IKO mice absorb fructose normally but are protected against dietary fructose-induced hepatic steatosis, without weight loss or changes in energy expenditure. In addition, Mttp-IKO mice exhibit altered cecal microbial communities, both at baseline and following fructose feeding, including increased abundance of Bacteroides and Lactobacillus genera. Transplantation of cecal microbiota from chow-fed Mttp-IKO mice into antibiotic-treated wild-type recipients conferred transmissible protection against fructose-induced hepatic steatosis in association with a bloom in Akkermansia and increased Clostridium XIVa genera, whose abundance was positively correlated with fecal coprostanol and total neutral sterol excretion in recipient mice. However, antibiotic-treated Mttp-IKO mice were still protected against fructose-induced hepatic steatosis, suggesting that changes in microbiota are not required for this phenotype. Nevertheless, we found increased abundance of fecal Akkermansia from two adult ABL subjects with MTTP mutations compared to their heterozygous parents and within the range noted in six healthy control subjects. Furthermore, Akkermansia abundance across all subjects was positively correlated with fecal coprostanol excretion. Conclusion: The findings collectively suggest multiple adaptive pathways of metabolic regulation following blocked chylomicron assembly, including shifts in BA signaling and altered microbial composition that confer a transmissible phenotype.
肠道胆汁酸(BA)代谢改变改善全身葡萄糖耐量和肝脏代谢稳态的机制尚不完全清楚。我们研究了条件性肠道载脂蛋白 E 缺乏症(ABL)基因微粒体甘油三酯转移蛋白(Mttp-IKO)缺失小鼠的代谢适应,该基因阻止乳糜微粒组装并损害肠道脂质转运。Mttp-IKO 小鼠表现出改善的肝葡萄糖代谢和增强的胰岛素信号传导,而没有体重减轻。这些适应包括 BA 排泄减少、池大小增加、BA 组成改变和成纤维细胞生长因子 15 产量增加。Mttp-IKO 小鼠正常吸收果糖,但免受饮食果糖诱导的肝脂肪变性的影响,而没有体重减轻或能量消耗的变化。此外,Mttp-IKO 小鼠表现出改变的盲肠微生物群落,无论是在基线还是在果糖喂养后,包括增加的 Bacteroides 和 Lactobacillus 属的丰度。将来自低脂饮食喂养的 Mttp-IKO 小鼠的盲肠微生物群移植到抗生素处理的野生型受体中,赋予了对果糖诱导的肝脂肪变性的可传播保护作用,伴随着 Akkermansia 的增加和 Clostridium XIVa 属的增加,其丰度与受体小鼠粪便粪甾醇和总中性固醇排泄呈正相关。然而,抗生素处理的 Mttp-IKO 小鼠仍然免受果糖诱导的肝脂肪变性的影响,这表明微生物群的变化不是这种表型所必需的。尽管如此,我们发现与他们的杂合父母相比,两名患有 MTTP 突变的 ABL 成年患者的粪便 Akkermansia 丰度增加,并且在六个健康对照者的范围内。此外,所有受试者的 Akkermansia 丰度与粪便粪甾醇排泄呈正相关。结论:这些发现共同表明,阻止乳糜微粒组装后存在多种代谢调节的适应性途径,包括 BA 信号转导和改变的微生物组成的变化,从而赋予可传播的表型。